Prevention and treatment of cryptococcal meningitis in patients with AIDS

CNS Drugs

Volumn 5, Issue 4, 1996, Pages 246-256

  Villanueva, Merceditas S ^a,b   Quagliarello, Vincent J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WATERBURY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CEREBROSPINAL FLUID; CRYPTOCOCCOSIS; HUMAN; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LUMBAR PUNCTURE; MENINGITIS; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW;

EID: 0029971445     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-199605040-00003     Document Type: Review

References (33)

1. Powderly WG. Cryptococcal meningitis and AIDS. Clin Infect Dis 1993; 17: 837-42
2. Diamond RD. Cryptococcus neoformans. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995: 2331-40
3. Kovacs JA, Kovacs AA, Polis M, et al. Cryptococcus in the acquired immunodeficiency syndrome. Ann Intern Med 1985; 103: 533-8
4. Zuger A, Louie E, Holzman RS, et al. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986; 104: 234-40
5. Chuck SL, Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989; 321: 794-9
6. Saag MS, Powderly WG, Cloud GA, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992; 326: 83-9
7. Eng RH, Bishburg E, Smith SM, et al. Cryptococcal infections in patients with acquired immune deficiency syndrome. Am J Med 1986; 81: 19-23
8. Larsen RA, Bozzette S, McCutchan JA. Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. Ann Intern Med 1989; 111: 125-8
9. Bennett JE, Dismukes WE, Duma RJ, et al. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med 1979; 301: 126-31
10. Kucers A, Kemp RJ. 5-Fluorocytosine. In: Kucers A, Kemp RJ, editors. The use of antibiotics. 4th ed. Philadelphia: JB Lippincott, 1987: 1534-47
11. Larsen RA, Leal ME, Chan LS. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. Ann Intern Med 1990; 113: 183-7
12. De Gans J, Portegies P, Tiessens G, et al. Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis. AIDS 1992; 6: 185-90
13. Van der Horst C, Saag M, Cloud G, et al. Part 1. Randomised double blind comparison of amphotericin B plus flucytosine (AMB + FC) to AMB alone (step 1) followed by a comparison of fluconazole to itraconazole (step 2) in the treatment of acute cryptococcal meningitis in patients with AIDS [abstract no. 1216]. In: 35th Interscience Conference on Antimicrobial Agents and Chemotherapy: 1995 Sept 17-20; San Francisco. Washington, DC: American Society for Microbiology, 1995
14. Galgiani JN. Fluconazole, a new antifungal agent. Ann Intern Med 1990; 113: 177-9
15. Saag M, Van der Horst C, Cloud G, et al. Part 2. Randomised double blind comparison of amphotericin B plus flucytosine (AMB + FC) to AMB alone (step 1) followed by a comparison of fluconazole to itraconazole (step 2) in the treatment of acute cryptococcal meningitis in patients with AIDS [abstract no. 1217]. In: 35th Interscience Conference on Antimicrobial Agents and Chemotherapy: 1995 Sept 17-20; San Francisco. Washington, DC: American Society for Microbiology, 1995
16. Larsen RA, Bozzette SA, Jones BE, et al. Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis 1994; 19: 741-5
17. Haubrich RH, Haghighat D, Bozzette SA, et al. High-dose fluconazole for treatment of cryptococcal disease in patients with human immunodeficiency virus infection. J Infect Dis 1994; 170: 238-42
18. Denning DW, Tucker RM, Hanson LH, et al. Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch Intern Med 1989; 149: 2301-8
19. Coker R, Tomlinson D, Harris J. Successful treatment of cryptococcal meningitis with liposomal amphotericin B after failure of treatment with fluconazole and conventional amphotericin B [letter]. AIDS 1991; 5: 231-2
20. Coker RJ, Murphy SM, Harris JRW. Experience with liposomal amphotericin B (ambisome) in cryptococcal meningitis in AIDS. J Antimicrob Chemother 1991; 28 Suppl. B: 105-9
21. Perfect JR, Wright KA. Ampholericin B lipid complex in the treatment of experimental cryptococcal meningitis and disseminated candidiasis. J Antimicrob Chemother 1994; 33: 73-81
22. Polsky B, Depman MR, Gold JWM, et al. Intraventricular therapy of cryptococcal meningitis via a subcutaneous reservoir. Am J Med 1986; 81: 24-8
23. Bozzette SA, Larsen RA, Chiu J, et al. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. N Engl J Med 1991; 324: 580-4
24. Powderly WG, Saag MS, Cloud GA, et al. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 1992; 326: 793-8
25. Powderly WG, Saag MS, Cloud GA, et al. Suppressive therapy for cryptococcal meningitis [letter]. N Engl J Med 1992; 327: 565-6
26. Paugam A, Dupouy-Camet J, Blanche P, et al. Increased fluconazole resistance of Cryptococcus neoformans isolated from a patient with AIDS and recurrent meningitis [letter]. Clin Infect Dis 1994; 19: 976-7
27. Saag M, Cloud G, Graybill JR, et al. Comparison of fluconazole (FLU) versus itraconazole (ITRA) as maintenance therapy of AIDS-associated cryptococcal meningitis (CM) [abstract no. 1218]. In: 35th Interscience Conference on Antimicrobial Agents and Chemotherapy: 1995 Sept 17-20; San Francisco. Washington, DC: American Society for Microbiology, 1995
28. Center for Disease Control. Recommendations for prophylaxis against Pneumocystis carinii pneumonia in adults and adolescents infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1992; 41: RR-4, 1-11
29. Girard PM, Landman R, Gaudebout C, et al. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis. N Engl J Med 1993; 328: 1514-20
30. Nightingale S, Cameron W, Gordin F, et al. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 1993; 329: 828-33
31. Nightingale SD, Cal SX, Peterson DM, et al. Primary prophylaxis with fluconazole against systemic fungal infections in HIV-positive patients. AIDS 1992; 6: 191-4
32. Quagliarello VJ, Viscoli C, Horwitz RI. Primary prevention of cryptococcal meningitis by fluconazole in HIV-infected patients. Lancet 1995; 345: 548-52
33. Powderly WG, Finkelstein MD, Feinberg J, et al. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. N Engl J Med 1995; 332: 700-5